These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28043903)

  • 61. Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study.
    Alvarez MA; Cabré E; Lorenzo-Zúñiga V; Montoliu S; Planas R; Gassull MA
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1375-80. PubMed ID: 15618848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Diagnostic and therapeutic strategies for severe alcoholic hepatitis].
    Kim W
    Korean J Gastroenterol; 2015 Jan; 65(1):4-11. PubMed ID: 25603848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized trial of prednisolone in patients with severe alcoholic hepatitis.
    Ramond MJ; Poynard T; Rueff B; Mathurin P; Théodore C; Chaput JC; Benhamou JP
    N Engl J Med; 1992 Feb; 326(8):507-12. PubMed ID: 1531090
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Therapeutic management of alcoholic hepatitis.
    Mathurin P
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S41-5. PubMed ID: 26189979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute Alcoholic Hepatitis: Therapy.
    Phillips PK; Lucey MR
    Clin Liver Dis; 2016 Aug; 20(3):509-19. PubMed ID: 27373613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.
    Naveau S; Chollet-Martin S; Dharancy S; Mathurin P; Jouet P; Piquet MA; Davion T; Oberti F; Broët P; Emilie D;
    Hepatology; 2004 May; 39(5):1390-7. PubMed ID: 15122768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.
    Higuera-de la Tijera F; Servín-Caamaño AI; Cruz-Herrera J; Serralde-Zúñiga AE; Abdo-Francis JM; Gutiérrez-Reyes G; Pérez-Hernández JL
    Ann Hepatol; 2014; 13(3):343-52. PubMed ID: 24756009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A prognostic evaluation and management of alcoholic hepatitis.
    Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
    Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection: A Randomized Clinical Trial.
    Hay AD; Little P; Harnden A; Thompson M; Wang K; Kendrick D; Orton E; Brookes ST; Young GJ; May M; Hollinghurst S; Carroll FE; Downing H; Timmins D; Lafond N; El-Gohary M; Moore M
    JAMA; 2017 Aug; 318(8):721-730. PubMed ID: 28829884
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
    Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
    J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
    [TBL] [Abstract][Full Text] [Related]  

  • 71. IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
    Szabo G; Mitchell M; McClain CJ; Dasarathy S; Barton B; McCullough AJ; Nagy LE; Kroll-Desrosiers A; Tornai D; Min HA; Radaeva S; Holbein MEB; Casey L; Cuthbert J
    Hepatology; 2022 Oct; 76(4):1058-1068. PubMed ID: 35340032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Infections complicating severe alcoholic hepatitis: Enterococcus species represent the most frequently identified pathogen.
    Beisel C; Blessin U; Schulze Zur Wiesch J; Wehmeyer MH; Lohse AW; Benten D; Kluwe J
    Scand J Gastroenterol; 2016 Jul; 51(7):807-13. PubMed ID: 27000534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alcoholic hepatitis: Prognosis and treatment.
    Casanova J; Bataller R
    Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infections in Alcoholic Hepatitis.
    Kaur B; Rosenblatt R; Sundaram V
    J Clin Transl Hepatol; 2022 Aug; 10(4):718-725. PubMed ID: 36062291
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimal management of alcoholic hepatitis.
    Raff E; Singal AK
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):25-38. PubMed ID: 24632766
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute Alcoholic Hepatitis.
    Im GY
    Clin Liver Dis; 2019 Feb; 23(1):81-98. PubMed ID: 30454835
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes.
    Potts JR; Howard MR; Verma S
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):659-64. PubMed ID: 23628964
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.
    Thompson J; Jones N; Al-Khafaji A; Malik S; Reich D; Munoz S; MacNicholas R; Hassanein T; Teperman L; Stein L; Duarte-Rojo A; Malik R; Adhami T; Asrani S; Shah N; Gaglio P; Duddempudi A; Borg B; Jalan R; Brown R; Patton H; Satoskar R; Rossi S; Parikh A; ElSharkawy A; Mantry P; Sher L; Wolf D; Hart M; Landis C; Wigg A; Habib S; McCaughan G; Colquhoun S; Henry A; Bedard P; Landeen L; Millis M; Ashley R; Frank W; Henry A; Stange J; Subramanian R;
    Liver Transpl; 2018 Mar; 24(3):380-393. PubMed ID: 29171941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk factors of infection-associated mortality in children with lupus nephritis in under-resourced areas.
    Rianthavorn P; Prurapark P
    Lupus; 2019 Dec; 28(14):1727-1734. PubMed ID: 31635558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.